Eureka Bio Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
35
- Latest Deal Type
-
2ndary - Private
- Investors
-
14
Eureka Bio General Information
Description
Developer of automated biotechnology platforms designed to address viral vector production challenges. The company's technology utilizes stable producer cell lines, serum-free suspension systems, closed automated tubing, centrifugal units, and continuous-flow processing, providing cell and gene therapy organizations with lentiviral vector production systems, automated cell processing equipment, and manufacturing solutions to reduce costs and enhance efficiency.
Contact Information
Website
www.eurekabio.comCorporate Office
- Room 801, Block A, Garden City Digital Building, Number 1079 Nanhai Avenue
- Yanshan Community, Zhaoshang Street, Nanshan District
- Shenzhen, Guangdong 518023
- China
Corporate Office
- Room 801, Block A, Garden City Digital Building, Number 1079 Nanhai Avenue
- Yanshan Community, Zhaoshang Street, Nanshan District
- Shenzhen, Guangdong 518023
- China
Eureka Bio Timeline
Eureka Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | 13-Jul-2026 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B1) | 02-Feb-2024 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 09-Jun-2022 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 23-Apr-2021 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 12-Oct-2020 | Completed | Generating Revenue | |||
| 1. Corporate | 03-Mar-2017 | Completed | Generating Revenue |
Eureka Bio Signals
Eureka Bio Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ABC Capital | Venture Capital | Minority | ||
| Fortune Capital | Venture Capital | Minority | ||
| Guangdong Technology Financial Group | Government | Minority | ||
| Guangzhou Yuexiu Industrial Investment Fund Management | PE/Buyout | Minority | ||
| Guli High-end Equipment | Accelerator/Incubator | Minority |
Eureka Bio FAQs
-
When was Eureka Bio founded?
Eureka Bio was founded in 2014.
-
Where is Eureka Bio headquartered?
Eureka Bio is headquartered in Shenzhen, China.
-
What is the size of Eureka Bio?
Eureka Bio has 35 total employees.
-
What industry is Eureka Bio in?
Eureka Bio’s primary industry is Discovery Tools (Healthcare).
-
Is Eureka Bio a private or public company?
Eureka Bio is a Private company.
-
What is Eureka Bio’s current revenue?
The current revenue for Eureka Bio is .
-
How much funding has Eureka Bio raised over time?
Eureka Bio has raised $57M.
-
Who are Eureka Bio’s investors?
ABC Capital, Fortune Capital, Guangdong Technology Financial Group, Guangzhou Yuexiu Industrial Investment Fund Management, and Guli High-end Equipment are 5 of 14 investors who have invested in Eureka Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process